Duke Clinical Research Institute (DCRI)
Duke Clinical Research Institute (DCRI) is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A prospective, open-label, single-arm, multicenter pharmacokinetic study evaluating the placental transfer of dapirolizumab pegol to the infant(s) from pregnant study participants with active systemic lupus erythematosus who are administered dapirolizumab pegol
Sponsor UCB Biopharma
- Start (EU)
- Not reported
- Latest update
- Estimated end
A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat/MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction
Sponsor Merck Sharp & Dohme LLC
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Duke Clinical Research Institute (DCRI)?
The 2026-10-09 snapshot links Duke Clinical Research Institute (DCRI) to 2 distinct CTIS trials. Recorded services include Clinical Event Adjudication serving as an independent reviewer of prespecified efficacy endpoints, Medical Expertise Thromboembolic Avents Adjudication. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Duke Clinical Research Institute (DCRI)?
The most frequently recorded therapeutic areas are Immunology, Rheumatology. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Duke Clinical Research Institute (DCRI) conducted?
The linked trials record locations in 14 countries, including Austria, Germany, Denmark, Spain, Greece. These are trial locations, not confirmed office locations or countries where Duke Clinical Research Institute (DCRI) delivered services.
What can this page tell me about Duke Clinical Research Institute (DCRI)'s trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Duke Clinical Research Institute (DCRI). Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Duke Clinical Research Institute (DCRI)